Pharma’s $100bn+ opportunity to redefine obesity treatment
Magazine article
Script headache
Exploring the disparities in drug availability and patient access
Data with destiny
The big next step for European Medicines Agency’s IDMP
Trials of the century
The idea of putting patients first must become a stark reality
Orwellian echoes
Doing politics like it’s 1984 is bad for the life sciences business
Taking off together
Leadership in partnership working – alignment to action
Big questions
WeightWatchers’ demise signals a new era for obesity treatment
Weight of expectation
Engaging patients during obesity trials and preparing them for life
Shake to undo
Pharma’s Chris Henry is back as he owns and observes his PD
Smart ease
Things that were moving gradually are now accelerating at AI speed
Grooving with the times
Women in Pharma founders reflect on their progress and ambitions
History lesson
Closing the evidence gap in women’s health – the need for inclusive research
Enemy of the state
What does AI mean for the future of cancer care?
Science friction
Preparing for an unknowable future that’s already arrived
AI knowing
AI is set to superpower the scientist in biopharma R&D
